First EU Nation OKs CanSino's One-Shot COVID Jab
Two Chinese Inhaled Candidates Also Coming
Executive Summary
China continues the global push for its domestically-developed COVID-19 vaccines, with a new approval in Eastern Europe and new delivery routes entering clinical trials.
You may also be interested in...
Setbacks For China Pharma As Firms Hit With Antitrust Fine, Clinical Setback
One of China's largest domestic pharma conglomerates has been fined more than $100m for price-fixing and other monopoly acts, while another firm has seen a major Phase III setback for its global launch hope.
Sinovac Real-World Data In Brazil Shed Fresh Light On China COVID Vaccine Efficacy Debate
Sinovac’s COVID-19 vaccine has an efficacy rate of 50% in one hard-hit region of Brazil, a study finds, which could fuel fresh doubts over the efficacy of Chinese vaccines and raise the urgency to change current vaccination strategy.
Sinovac Real World Data Shed Fresh Light On China COVID Vaccine Efficacy Debate
New real world data for Sinovac’s COVID-19 vaccine from hard-hit Brazil could fuel fresh doubts over the efficacy of Chinese vaccines, but also raise the urgency to change current vaccination strategy.